Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications multinational drug utilisation study investigate use dexmedetomidine dexdor�� clinical 1
… by the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) for cancer treatment found that the agencies use different standards to evaluate evidence from patient-reported outcomes (PROs) in clinical trials. Study sponsors pursuing PRO drug labeling …
… if: The dosing regimen changes from 3 times a day to 1? Length of treatment decreases to 5 days instead of 10? The … approach to WTP ensures actionable results to inform your drug development and market access strategies. For your … and administer the survey: We recruit subjects for each study that are representative of the target patient …
… about your new product, we can help you understand the clinical and economic evidence they will expect to see for … impact your product’s market access Product value summary: Clinical, economic , humanistic, and comparative value … in accordance with Section 114 of the 1997 Food and Drug Administration Modernization Act Summaries of relevant …
… Modeling Approaches to Assess Association Between Two Clinical Outcomes Assessments Bintu Sherif, MS Director, … regulatory focus on incorporating patient perspectives in drug development, patient-reported outcomes, known as PROs, … the relationship across time-points. Our goal for this study, was to demonstrate the advantages of using …
… Sciences, Engineering, and Medicine (NASEM) will conduct a study in the United States and the European Union on the … MD, PhD, to present at an upcoming meeting for the study. During the Novel Methodologies session, Dr. Garcia de … of task. These include, but are not limited to: The use of regulatory flexibilities and supplementary data (e.g., …
… more opportunities to get the most value out of your study, whether exploratory or pre-specified. After analyzing … of your analyses clear, understandable, and ready to use for publication and other communications to stakeholders. … of results Support for scientific presentations and publications And each step will be delivered with the rigor …
… in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials Margaret Mordin, MS Vice President, Market … 2013, there was an increase in the number of trials that use a patient reported outcome (PRO) measure, particularly in … the US FDA has advocated for including patients’ voice in drug development and has issued new guidelines on how to do …
… review of burden of illness Systematic reviews of clinical literature Systematic reviews of utility, and … and frequentist methods) Utility research and resource use/cost estimation Cost effectiveness analyses Budget impact …
… looking for consulting advice ; database or registry study; prospective observational research ; a literature … Dr. Alicia Gilsenan – Member of the Program Committee of Drug Information Association (DIA) , Adjunct Professor, … companies reduce the uncertainty of risks to patients who use their products. …
… of life, functional status, and patient satisfaction for use in clinical trials involving both pediatric and adult patients … including regulatory submissions, reports, and publications Support to secure regulatory acceptability of …